Terrie Curran, President and Chief Executive: Phathom Pharmaceuticals PHAT Sell · Filed 24/03/26

Trade details

Type: Insider sale
Amount: $153,512.61
Shares · price: 16,851 sh · $9.11 a share
Held after: 410,784 sh
Stock: Phathom Pharmaceuticals PHAT
Person: Terrie CurranPresident and Chief Executive
Trade date: 24/03/22
Filed: 24/03/26
Days to filing: 4 days

Sold 3.9% of holdings

Share of holding sold: 3.9%

Phathom Pharmaceuticals trades, last 26 weeks

What else happened in Phathom Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/02/21~24/04/21

Terrie Curran's recent trades

Terrie CurranDirector
Planned saleArcutis Biotherapeutics
Planned sale
Arcutis Biotherapeutics
ARQT
$956.1K
38,200 sh
$956.1K
Filed 08/27
Traded 08/27
Terrie CurranDirector
Planned saleArcutis Biotherapeutics
Planned sale
Arcutis Biotherapeutics
ARQT
$27.9K
1,072 sh
$27.9K
Filed 08/20
Traded 08/20
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$125.9K
19,109 sh
$125.9K
Filed 25/01/23
Traded 25/01/21
Terrie CurranDirector
SellArcutis Biotherapeutics
Sell
Arcutis Biotherapeutics
ARQT
$94.3K
8,687 sh
$94.3K
Filed 24/11/13
Traded 24/11/11
Terrie CurranPresident and Chief Executive
SellPhathom Pharmaceuticals
Sell
Phathom Pharmaceuticals
PHAT
$396.7K
33,848 sh
$396.7K
Filed 24/07/17
Traded 24/07/15